Roche Holding AG (RHHBY)
61.17
+1.55
(+2.60%)
USD |
OTCM |
Oct 23, 16:00
Roche Market Cap : 337.70B for Oct. 23, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 23, 2026 | 337.70B |
| October 22, 2026 | 329.14B |
| October 21, 2026 | 326.32B |
| October 20, 2026 | 326.32B |
| October 19, 2026 | 315.45B |
| October 16, 2026 | 315.45B |
| October 15, 2026 | 313.46B |
| October 14, 2026 | 307.44B |
| October 13, 2026 | 296.84B |
| October 12, 2026 | 298.66B |
| October 09, 2026 | 298.61B |
| October 08, 2026 | 294.63B |
| October 07, 2026 | 298.50B |
| October 06, 2026 | 290.11B |
| October 05, 2026 | 289.89B |
| October 02, 2026 | 288.45B |
| October 01, 2026 | 289.00B |
| September 30, 2026 | 286.41B |
| September 29, 2026 | 288.45B |
| September 28, 2026 | 294.63B |
| September 25, 2026 | 300.60B |
| September 24, 2026 | 302.53B |
| September 23, 2026 | 303.96B |
| September 22, 2026 | 307.28B |
| September 21, 2026 | 305.29B |
| Date | Value |
|---|---|
| September 18, 2026 | 298.94B |
| September 17, 2026 | 301.59B |
| September 16, 2026 | 304.46B |
| September 15, 2026 | 303.33B |
| September 14, 2026 | 302.53B |
| September 11, 2026 | 291.21B |
| September 10, 2026 | 293.64B |
| September 09, 2026 | 294.69B |
| September 08, 2026 | 298.50B |
| September 04, 2026 | 303.44B |
| September 03, 2026 | 304.85B |
| September 02, 2026 | 297.17B |
| September 01, 2026 | 293.09B |
| August 31, 2026 | 296.46B |
| August 28, 2026 | 304.68B |
| August 27, 2026 | 311.31B |
| August 26, 2026 | 314.07B |
| August 25, 2026 | 322.79B |
| August 24, 2026 | 317.27B |
| August 21, 2026 | 320.75B |
| August 20, 2026 | 316.05B |
| August 19, 2026 | 321.30B |
| August 18, 2026 | 306.53B |
| August 17, 2026 | 301.48B |
| August 14, 2026 | 300.98B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Novartis AG | 281.55B |
| AstraZeneca PLC | 533.58B |
| GSK Plc | 103.38B |
| Johnson & Johnson | 641.50B |
| Eli Lilly & Co. | 1.205T |
Market Cap Related Metrics
| PE Ratio | 25.31 |
| PS Ratio | 5.128 |
| PEG Ratio | 0.8491 |
| Price to Free Cash Flow | 24.06 |
| Price | 61.17 |
| Earnings Yield | 3.95% |
| PEGY Ratio | 0.7826 |
| Operating PE Ratio | 16.72 |
| Normalized PE Ratio | 21.21 |